Impact of Three Months Metformin Treatment on VLDL-TG Metabolism in Healthy Subjects and Patients with Type 2 Diabetes

被引：0
|
作者：
Gormsen, Lars C.
Sondergaard, Esben
Christensen, Nana
Tolbod, Lars P.
Nielsen, Soren
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1952-P
引用
收藏
页码：A516 / A516
页数：1
相关论文
共 50 条
  • [41] Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
    Gout-Zwart, Judith J.
    de Jong, Lisa A.
    Saptenno, Lisanne
    Postma, Maarten J.
    PHARMACOECONOMICS-OPEN, 2020, 4 (02) : 321 - 330
  • [42] COMPLIANCE WITH METFORMIN TREATMENT IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS: A SINGLE DIABETES CENTRE CROSS-SECTIONAL STUDY
    Mraz, M.
    Prokopova, I.
    Lankova, I.
    Cajka, T.
    Hricko, J.
    Hradkova, V.
    Vlasakova, Z.
    Pelikanova, T.
    Haluzik, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A245 - A246
  • [43] Effects of different metformin treatment dose for 6 months on rectal aberrant crypt foci in patients with newly diagnosed type 2 diabetes
    Chen, Mingwei
    Zhao, Xiaotong
    Zhang, Qunhui
    Chen, Yan
    Wang, Yalei
    Xie, Huijuan
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [44] The impact of metformin on mortality in patients with type 2 diabetes mellitus: a prospective cohort study
    Zhang, Bocheng
    Cao, Ying
    Qu, Zhenan
    Sun, Yulan
    Tian, Xiaoyuan
    ENDOCRINE, 2025, 87 (01) : 136 - 143
  • [45] Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
    Kun Wang
    Lingge Feng
    Jiayi Zhang
    Quanfei Zou
    Fengyan Xu
    Zhongyi Sun
    Fuxing Tang
    Li Chen
    Clinical Pharmacokinetics, 2023, 62 : 1413 - 1425
  • [46] Insulin secretion in healthy subjects and patients with Type 2 diabetes - role of the gastrointestinal tract
    Ma, Jing
    Rayner, Christopher K.
    Jones, Karen L.
    Horowitz, Michael
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 413 - 424
  • [47] Population Pharmacokinetic Analysis of Dorzagliatin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus
    Wang, Kun
    Feng, Lingge
    Zhang, Jiayi
    Zou, Quanfei
    Xu, Fengyan
    Sun, Zhongyi
    Tang, Fuxing
    Chen, Li
    CLINICAL PHARMACOKINETICS, 2023, 62 (10) : 1413 - 1425
  • [48] Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
    Fediuk, Daryl J.
    Zhou, Susan
    Dawra, Vikas Kumar
    Sahasrabudhe, Vaishali
    Sweeney, Kevin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 696 - 706
  • [49] THE EFFECT OF METFORMIN ON ENERGETIC METABOLISM IN PATIENTS WITH TYPE 2 DIABETES/PREDIABETES AND CHRONIC HEART FAILURE
    Stolarikova, E.
    Kopecky, J.
    Velebova, K.
    Veleba, J.
    Belinova, L.
    Malinska, H.
    Segetova, M.
    Melenovsky, V.
    Pelikanova, T.
    ATHEROSCLEROSIS, 2018, 275 : E195 - E195
  • [50] Results of three Months of Insulin Therapy with PAQ® in Female Patients with Type 2 Diabetes
    Poettler, Tina
    Lilly, Leslie C.
    Aberer, Felix
    Trautmann, Michael
    Warner, Jay
    Pieber, Thomas R.
    Mader, Julia K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 : 173 - 173
12345